Adma Biologics (ADMA) Amortization of Deferred Charges (2013 - 2023)
Adma Biologics (ADMA) reported Amortization of Deferred Charges of $877000.0 for Q4 2023, down 9.97% on a YoY basis from $974068.0 in Q4 2022, and down 11.68% quarter-over-quarter from $993000.0 in Q3 2023.
Adma Biologics (ADMA) Amortization of Deferred Charges (2013 - 2023) Analysis & Trends
Adma Biologics has reported Amortization of Deferred Charges for 3 years, with the latest figure at $877000.0 in Q4 2023.
- For the quarter ending Q4 2023, Amortization of Deferred Charges fell 9.97% year-over-year to $877000.0; the trailing twelve-month figure through Sep 2024 stood at $877000.0 (down 77.7% YoY), and the FY2023 full-year result was $3.8 million, up 27.95% from the prior year.
- Amortization of Deferred Charges for Q4 2023 stood at $877000.0, down from $993000.0 in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $1.0 million in Q2 2022, with the low at $877000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Adma Biologics | 1.98 Bn | 1.89 Bn | 88.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 877,000.00 |
| Dec 31, 2023 | 877,000.00 |
| Sep 30, 2023 | 993,000.00 |
| Sep 30, 2023 | 993,000.00 |
| Jun 30, 2023 | 986,000.00 |
| Jun 30, 2023 | 986,000.00 |
| Mar 31, 2023 | 980,000.00 |
| Mar 31, 2023 | 980,000.00 |
| Dec 31, 2022 | 974,068.00 |
| Dec 31, 2022 | 974,068.00 |
| Sep 30, 2022 | 978,272.00 |
| Sep 30, 2022 | 978,272.00 |
| Jun 30, 2022 | 1.05 Mn |
| Jun 30, 2022 | 1.05 Mn |
| Mar 31, 2013 | 20,640.00 |
| Mar 31, 2013 | 20,640.00 |